Evidence comparison
Incretin medicine vs. teriparatide: evidence fields
These medicines have different approved indications and evidence bases; this comparison does not recommend switching or combining therapies.
| Field | Semaglutide | Teriparatide |
|---|---|---|
| Primary approved use | Type 2 diabetes / chronic weight management. | Osteoporosis in postmenopausal women and men at high fracture risk. |
| Peptide relationship | GLP-1 analog | PTH fragment |
| Key women's evidence | Obesity/diabetes trials enrolled majorities of women; sex subgroup analyses are reported but limited. | Pivotal fracture trial in 1,637 postmenopausal women with osteoporosis. |
Sources
Primary records
- regulatory label
Gateway to current FDA-approved prescribing information. Confirm the exact product label before clinical use.
- peer reviewed article
Index of peer-reviewed biomedical literature.
Medical disclaimer: Her Health Peptides publishes educational, source-linked summaries. We do not provide individualized medical advice, diagnosis, or treatment recommendations. Always talk with a licensed clinician about your specific situation, especially if you are pregnant, breastfeeding, planning pregnancy, or taking other medicines.